"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"AstraZeneca","AstraZeneca","$250,000","$0","$250,000","2011","20110606","employment-related offenses","employment discrimination","","AstraZeneca agreed to pay $250,000 to 124 women who allegedly were subjected to pay discrimination while working at the corporation's Philadelphia Business Center in Wayne, Pa. The action resolved a lawsuit filed by the U.S. Department of Labor in May 2010 alleging that the company discriminated against female sales specialists by paying them salaries that were, on average, $1,700 less than their male counterparts. ","federal","agency action","Office of Federal Contract Compliance Programs","civil","","","","","","Pennsylvania","Wayne","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.dol.gov/opa/media/press/ofccp/OFCCP20110829.htm",""
"AstraZeneca LP","AstraZeneca","$520,000,000","$0","$520,000,000","2010","20100427","healthcare-related offenses","off-label or unapproved promotion of medical products","","AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration, the Departments of Justice and Health and Human Services' Health Care Fraud Enforcement Action Team.","federal","agency action","Food and Drug Administration referral to the Justice Department","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","http://www.justice.gov/opa/pr/pharmaceutical-giant-astrazeneca-pay-520-million-label-drug-marketing",""
"AstraZeneca LP","AstraZeneca","$46,500,000","$0","$46,500,000","2015","20150706","government-contracting-related offenses","False Claims Act and related","","AstraZeneca LP agreed to pay the United States and participating states a total of $46.5 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/astrazeneca-and-cephalon-pay-465-million-and-75-million-respectively-allegedly-underpaying",""
"AstraZeneca LP","AstraZeneca","$7,900,000","$0","$7,900,000","2015","20150211","government-contracting-related offenses","False Claims Act and related","kickbacks and bribery","AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/astrazeneca-pay-79-million-resolve-kickback-allegations",""
"AstraZeneca Pharmaceuticals","AstraZeneca","$2,600,000","$0","$2,600,000","2009","20091019","government-contracting-related offenses","False Claims Act and related","","Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals and Ortho McNeil Pharmaceutical entered into settlement agreements for a total of $124 million to resolve claims that they violated the False Claims Act by failing to pay appropriate rebates to state Medicaid programs for drugs paid for by those programs.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/four-pharmaceutical-companies-pay-124-million-submission-false-claims-medicaid",""
"AstraZeneca Pharmaceuticals LP","AstraZeneca","$354,900,000","$0","$354,900,000","2003","20030620","government-contracting-related offenses","False Claims Act and related","","AstraZeneca Pharmaceuticals LP pleaded guilty in federal district court in Wilmington, Delaware and agreed to pay $354.9 million to resolve criminal charges and civil liabilities in connection with its drug pricing and marketing practices with regard to Zoladex, a drug used primarily for the treatment of prostate cancer. AstraZeneca agreed to pay a criminal fine of $63.9 million as part of pleaded guilty to conspiring to violate the Prescription Drug Marketing Act by causing to be submitted claims for payment for the prescription of Zoladex which had been provided as free samples to urologists. AstraZeneca agreed to settle its federal civil False Claim Act liabilities and to pay the U.S. government $266.1 million to resolve allegations it caused false and fraudulent claims to be filed with the Medicare; another $24.9 million was to be paid to states to resolve similar claims concerning Medicaid.","federal","agency action","Justice Department Civil Division","civil and criminal","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.justice.gov/archive/opa/pr/2003/June/03_civ_371.htm",""
"AstraZeneca PLC","AstraZeneca","$5,522,000","$0","$5,522,000","2016","20160830","competition-related offenses","kickbacks and bribery","","","federal","agency action","Securities and Exchange Commission","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.sec.gov/litigation/admin/2016/34-78730.pdf",""
"AstraZeneca","AstraZeneca","$350,000","$0","$350,000","2008","20080328","employment-related offenses","employment discrimination","age discrimination","","state","private litigation","","civil","","Livingston County (Michigan) Circuit Court","06-022564-CL","Robert Strain v. AstraZeneca","settlement","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","2008 Jury Verdicts LEXIS 39768",""
"Alexion Pharmaceuticals Inc.","AstraZeneca","$13,000,000","$0","$13,000,000","2019","20190404","government-contracting-related offenses","False Claims Act and related","kickbacks and bribery","Three pharmaceutical companies -- Jazz Pharmaceuticals plc, Lundbeck LLC, and Alexion Pharmaceuticals Inc. -- agreed to pay a total of $122.6 million to resolve allegations that they each violated the False Claims Act by illegally paying the Medicare or Civilian Health and Medical Program (ChampVA) copays for their own products, through purportedly independent foundations that the companies used as mere conduits.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/three-pharmaceutical-companies-agree-pay-total-over-122-million-resolve-allegations-they-paid",""
"AstraZeneca","AstraZeneca","$807,826","$0","$807,826","2004","20040122","government-contracting-related offenses","False Claims Act and related","","AstraZeneca agreed to pay $807,826 in settlement of allegations it overcharged Medicaid for the drug Zoladex by not including promotions, free goods, discounts, rebates, and other price reductions in the price paid by Florida's Medicaid Program.","state","agency action","Florida Attorney General","civil","","","","","","Florida","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20041213092454/http://myfloridalegal.com/newsrel.nsf/newsreleases/6AF7FEBC6494C36585256E23006CDACB",""
"AstraZeneca","AstraZeneca","$5,500,000","$0","$5,500,000","2013","20130207","healthcare-related offenses","off-label or unapproved promotion of medical products","","AstraZeneca agreed to pay $5.5 million in settlement of allegations it illegally promoted its drug Seroquel for uses that were not approved by the Food and Drug Administration.","state","agency action","Kentucky Attorney General","civil","","","","","","Kentucky","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20140901194126/http://migration.kentucky.gov/Newsroom/ag/seroquelsettlement.htm",""
"AstraZeneca","AstraZeneca","$5,391,000","$0","$5,391,000","2010","20100127","consumer-protection-related offenses","consumer protection violation","","Following an earlier guilty verdict at trial, AstraZeneca was ordered to pay $5.3 million in civil penalties for violations of the Kentucky Consumer Protection Act for its misreporting the average wholesale price of its drugs.","state","agency action","Kentucky Attorney General","civil","","","","","","Kentucky","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20100814195013/http://migration.kentucky.gov/Newsroom/ag/astrazenecacivil.htm",""
"AstraZeneca","AstraZeneca","$14,700,000","$0","$14,700,000","2009","20091015","government-contracting-related offenses","False Claims Act and related","","AstraZeneca was found guilty by a jury of defrauding Kentucky Medicaid by declaring inflated average wholesale prices of its drugs and was ordered to pay $14.7 million.","state","agency action","Kentucky Attorney General","civil","","","","","","Kentucky","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20100815134454/http://migration.kentucky.gov/Newsroom/ag/astrazenecaverdict.htm",""
"AstraZeneca","AstraZeneca","$110,000,000","$0","$110,000,000","2018","20180807","government-contracting-related offenses","False Claims Act and related","off-label or unapproved promotion of medical products","AstraZeneca agreed to pay $110 million to the state of Texas to settle lawsuits alleging that the company falsely and misleadingly marketed two of its drugs in violation of the Texas Medicaid Fraud Prevention Act.","state","agency action","Texas Attorney General","civil","","","","","","Texas","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.texasattorneygeneral.gov/news/releases/ag-paxton-recovers-110-million-texas-medicaid-fraud-settlements",""
"AstraZeneca LP","AstraZeneca","$46,500,000","$46,500,000","$0","2015","20151104","government-contracting-related offenses","False Claims Act and related","","AstraZeneca argeed to pay $46.5 million to settle multistate allegations that it overcharged state Medicaid programs for pharmaceutical products by underpaying drug rebates owed to the states. Also involved in the settlement was the federal government, which issued its own announcement; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-astrazeneca-lp-1","state","agency action","Multistate Attorneys General Case","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20170716210609/https://ag.ny.gov/press-release/ag-schneiderman-announces-54-million-multistate-settlement-astrazeneca-lp-and-cephalon",""
"AstraZeneca Pharmaceuticals","AstraZeneca","$68,500,000","$0","$68,500,000","2011","20110310","healthcare-related offenses","off-label or unapproved promotion of medical products","drug or medical equipment safety violation","AstraZeneca Pharmaceuticals agreed to pay $68.5 million to settle multistate litigation alleging unfair and deceptive practices in its marketing of the antipsychotic drug Seroquel, including promotion of the drug for unapproved uses, failure to adequately disclose potential side effects to health care providers, and withholding of scientific studies that called into question the drug's safety and efficacy.","state","agency action","Multistate Attorneys General Case","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.oag.ca.gov/news/press-releases/attorney-general-kamala-d-harris-and-37-other-attorneys-general-announce-685",""
"AstraZeneca Pharmaceuticals LP","AstraZeneca","$24,900,000","$24,900,000","$0","2003","20030630","government-contracting-related offenses","False Claims Act and related","","AstraZeneca agreed to pay $24.9 million to state attorneys general and federal agencies to resolve allegations that it caused false and fraudulent claims to be filed with the states as a result of its pricing and marketing misconduct relating to the prostate cancer drug Zoladex and that it failed to provide the state Medicaid programs its best price for the drug as required by law. This was part of a larger $354.9 million civil and criminal settlement negoltiated by the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-astrazeneca-pharmaceuticals-lp","state","agency action","Multistate Attorneys General Case","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.justice.gov/archive/opa/pr/2003/June/03_civ_371.htm",""
"AstraZeneca Pharmaceuticals LP","AstraZeneca","$2,600,000","$2,600,000","$0","2009","20091019","government-contracting-related offenses","False Claims Act and related","","AstraZeneca agreed to pay $2.6 million to settle multistate litigation claiming it violated the False Claims Act by failing to pay appropriate rebates for drugs that were paid for by Medicaid. Also involved in the settlement was the U.S. Justice Department, which made its own announcement; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-astrazeneca-pharmaceuticals","state","agency action","Multistate Attorneys General Case","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20100213182921/http://www.ag.ny.gov/media_center/2009/oct/oct19a_09.html",""
"AstraZeneca Pharmaceuticals LP","AstraZeneca","$218,092,993","$218,092,993","$0","2010","20100427","healthcare-related offenses","off-label or unapproved promotion of medical products","","AstraZeneca agreed to pay $218 million to settle multistate litigation regarding its practice of promoting its blockbuster antipsychotic drug Seroquel for unapproved uses. This was part of a larger $520 million settlement also involving the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-astrazeneca-lp","state","agency action","Multistate Attorneys General Case","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/pharmaceutical-giant-astrazeneca-pay-520-million-label-drug-marketing",""
"AstraZeneca Pharmaceuticals LP and AstraZeneca LP","AstraZeneca","$2,500,000","$0","$2,500,000","2011","20110811","government-contracting-related offenses","False Claims Act and related","","AstraZeneca Pharmaceuticals LP and AstraZeneca LP agreed to pay $2.5 million in settlement of allegations they misreported the average wholesale price of their drugs.  ","state","agency action","Idaho Attorney General","civil","","","","","","Idaho","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20120513204237/http://www.ag.idaho.gov/media/newsReleases/2011/nr_08112011.html",""
"AstraZeneca Pharmaceuticals, LP","AstraZeneca","$3,333,333","$0","$3,333,333","2010","20101006","government-contracting-related offenses","False Claims Act and related","","AstraZeneca, GlaxoSmithKline and Novartis together agreed to pay $10 million as part of a series of settlements between pharmaceutical companies and Hawaii of allegations that they published inflated prices for drugs and thus increased Medicaid costs. The announcement did not specify how that amount would be split among the three companies. Here we assume it was divided evenly among them.","state","agency action","Hawaii Attorney General","civil","","","","","","Hawaii","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","http://ag.hawaii.gov/wp-content/uploads/2012/12/2010-21.pdf",""
"Alexion Pharmaceuticals Inc.","AstraZeneca","$21,000,000","$0","$21,000,000","2020","20200702","competition-related offenses","Foreign Corrupt Practices Act","financial institution supervision failures","The SEC found that two Alexion subsidiaries made payments to foreign government officials to secure favorable treatment for Alexion's drug Soliris.","federal","agency action","Securities and Exchange Commission","civil","","","","","","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.sec.gov/news/press-release/2020-149",""
"AstraZeneca","AstraZeneca","$560,000","$0","$560,000","2021","20210930","employment-related offenses","employment discrimination","","","federal","agency action","Office of Federal Contract Compliance Programs","civil","","","","","","Delaware","Wilmington","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.dol.gov/sites/dolgov/files/OFCCP/foia/files/20210930-AstraZeneca-MA_CA_Redacted.pdf",""
"AstraZeneca","AstraZeneca","$198,000,000","$0","$198,000,000","2010","20100810","safety-related offenses","drug or medical equipment safety violation","product safety violation","AstraZeneca agreed to pay $198 million to settle multi-district litigation alleging that its anti-psychotic drug Seroquel created an elevated risk for diabetes.","federal","private litigation","","civil","","Middle District of Florida","6:06md1769","In Re: Seroquel Products Liability Litigation","settlement","","","","","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","https://www.law360.com/articles/186391/astrazeneca-to-pay-198m-to-end-seroquel-suits",""
"ALEXION PHARMACEUTICALS, INC.","AstraZeneca","$8,213","$0","$8,213","2012","20120725","safety-related offenses","workplace safety or health violation","","","federal","agency action","Occupational Safety & Health Administration","civil","","","","","","Rhode Island","SMITHFIELD","100 TECHNOLOGY WAY","02917","325414","325414: Biological Product (except Diagnostic) Manufacturing","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","Extracted from a download of OSHA's Enforcment Data downloaded on 3/02/2022, available at https://enforcedata.dol.gov/views/data_catalogs.php",""
"MEDIMMUNE DISTRIBUTION LLC","AstraZeneca","$21,125","$0","$21,125","2005","20051007","environment-related offenses","environmental violation","","","federal","agency action","Environmental Protection Agency","civil","","","04-2006-2000","","","Kentucky","SHEPHEDSVILLE","355 OMICRON COURT","40165","","","United Kingdom","","publicly traded","LSE: AZN","pharmaceuticals","pharmaceuticals","Extracted from a download of the EPA's Enforcement and Compliance History Online (ECHO) ICIS FE&C file downloaded on 3/02/2022, available at http://echo.epa.gov/tools/data-downloads#downloads",""
